Biological variation of total, free and percent free serum prostate specific antigen levels in screening volunteers

Journal of Urology

Volumn 157, Issue 6, 1997, Pages 2179-2182

  Ornstein, David K ^a   Smith, Deborah S ^a   Rao, Ganesh S ^a   Basler, Joseph W ^a   Ratliff, Timothy L ^a   Catalona, William J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ejaculation; prostate; prostate specific antigen; prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; BLOOD SAMPLING; CANCER SCREENING; EJACULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE DISEASE;

EID: 0030909789     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)64708-6     Document Type: Article

References (19)

1. Catalona, W. J., Smith, D. S., Ratliff, T. L., Dodds, K. M., Coplen, D. E., Yuan, J. J. J., Petros, J. A. and Andriole, G. L.: Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. New Engl. J. Med., 324: 1156, 1991.
2. Partin, A. W. and Oesterling, J. E.: The clinical usefulness of prostate specific antigen: update 1994. J. Urol., 152: 1358, 1994.
3. Catalona, W. J., Richie, J. P., Ahmann, F. R., Hudson, M. A., Scardino, P. T., Flanigan, R. C., deKernion, J. B., Ratliff, T. L., Kavoussi, L. R., Dalkin, B. L., Waters, W. B., MacFarlane, M. T. and Southwick, P. C.: Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J. Urol., 151: 1283, 1994.
4. Fritsche, H. A. and Babaian, R. J.: Analytical performance goals for measuring prostate-specific antigen. Clin. Chem., 39: 1525, 1993.
5. Yuan, J. J. J., Coplen, D. E., Petros, J. A., Figenshau, R. S., Ratliff, T. L., Smith, D. S. and Catalona, W. J.: Effects of rectal examination, prostatic massage, ultrasonography and needle biopsy on serum prostate specific antigen levels. J. Urol., 147: 810, 1992.
6. Bunting, P. S.: A guide to the interpretation of serum prostate specific antigen levels. Clin. Biochem., 28: 221, 1995.
7. Tchetgen, M. B., Song, J. T., Strawderman, M., Jacobson, S. J. and Oesterling, J. E.: Ejaculation increases the serum prostate-specific antigen concentration. Urology, 47: 511, 1996.
8. Schellhammer, P. F. and Wright, G. L., Jr.: Biomolecular and clinical characteristics of PSA and other candidate prostate tumor markers. Urol. Clin. N. Amer., 20: 597, 1993.
9. Prestigiacomo, A. F. and Stamey, T. A.: Physiological variation of serum prostate specific antigen in the 4.0 to 10.0 ng./ml. range in male volunteers. J. Urol., 155: 1977, 1996.
10. El-Shirbiny, A. M., Nilson, T. and Pawar, H. N.: Serum prostate specific antigen: hourly change/24 hours compared with prostatic acid phophatase. Urology, 35: 88, 1990.
11. Dejter, S. W., Jr., Martin, J. S., McPherson, R. A. and Lynch, J. H.: Daily variability in human serum prostate-specific antigen and prostatic acid phosphatase: a comparative evaluation. Urology, 32: 288, 1988.
12. Riehmann, M., Rhodes, P. R., Cook, T. D., Grose, G. S. and Bruskewitz, R. C.: Analysis of variation in prostate-specific antigen values. Urology, 42: 390, 1993.
13. Roehrborn, C. G., Pickens, G. J. and Carmody, T., III: Variability of repeated serum prostate-specific antigen (PSA) measurements within less than 90 days in a well-defined patient population. Urology, 47: 59, 1996.
14. Lilja, H., Christensson, A., Dahlén, U., Matikainen, M.-J., Nilsson, O., Pettersson, K. and Lovgren, T.: Prostate-specific antigen in serum occurs predominantly in complex with α1-antichymoptrypsin. Clin. Chem., 37: 1618, 1991.
15. Luderer, A. A., Chen, Y. T., Soriano, T. F., Kramp, W. J., Carlson, G., Cuny, C., Sharp, T., Smith, W., Petteway, J., Brawer, M. K. and Thiel, R.: Measurement of the proportion of free to total prostate-specific antigen improves diagnostic performance of prostate-specific antigen in the diagnostic gray zone of total prostate-specific antigen. Urology, 46: 187, 1995.
16. Catalona, W. J., Smith, D. S., Wolfert, R. L., Wang, T. J., Rittenhouse, H. G., Ratliff, T. L. and Nadler, R. B.: Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. J.A.M.A., 274: 1214, 1995.
17. Chen, Y. T., Luderer, A. A., Thiel, R. P., Carlson, G., Cuny, C. L. and Soriano, T. F.: Using proportions of free to total prostate-specific antigen, age, and total prostate-specific antigen to predict the probability of prostate cancer. Urology, 47: 518, 1996.
18. Glenski, W. J., Klee, G. G., Bergstralh, E. J. and Oesterling, J. E.: Prostate-specific antigen: establishment of the reference range for the clinically normal prostate gland and the effect of digital rectal examination, ejaculation, and time on serum concentrations. Prostate, 21: 99, 1992.
19. Komatsu, K., Wehner, N., Prestigiacomo, A. F., Chen, Z. and Stamey, T. A.: Physiologic (intraindividual) variation of serum prostate-specific antigen in 814 men from a screening population. Urology, 47: 343, 1996.